Immune checkpoint inhibitors are cancer drugs that for many have been a lifeline. Yet they are associated with a range of reactions that really need to be cataloged so they’re easier to recognize, some experts argue. Johns Hopkins Kimmel Cancer … <a class="more-link" href="https://podcasts.hopkinsmedicine.org/possible-impacts-of-new-cancer-drugs-need-to-be-cataloged-elizabeth-tracey-reports/"> Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports Read More »</a>

Immune checkpoint inhibitors are cancer drugs that for many have been a lifeline. Yet they are associated with a range of reactions that really need to be cataloged so they’re easier to recognize, some experts argue. Johns Hopkins Kimmel Cancer … Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports Read More »

Immune checkpoint inhibitors are cancer drugs that for many have been a lifeline. Yet they are associated with a range of reactions that really need to be cataloged so they’re easier to recognize, some experts argue. Johns Hopkins Kimmel Cancer … <a href="https://podcasts.hopkinsmedicine.org/possible-impacts-of-new-cancer-drugs-need-to-be-cataloged-elizabeth-tracey-reports/" rel="noopener noreferrer"> Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports Read More »</a>

Share Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports

Sign up to save your podcasts

Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports

Possible impacts of new cancer drugs need to be cataloged, Elizabeth Tracey reports